(ferrous asparto glycinate, iron, ascorbic acid, folic acid, cyanocobalamin, zinc, succinic acid, and intrinsic factor) Tablets
|Supplement Facts Serving Size: 1 tablet|
|Amount per Serving:||% Daily Value|
|Iron (as Sumalate® (ferrous asparto glycinate 50 mg) 150 mg and polysaccharide iron complex 100 mg)||150 mg||833%|
|Vitamin C (as ascorbic acid)||60 mg||100%|
|Folate (as 1.4 mg Quatrefolic® ((6S)-5, methyltetrahydrofolate glucosamine salt molar equivalent to 750 mcg of folic acid) and folic acid, USP 250 mcg)||1 mg||250%|
|Vitamin B12 (as cyanocobalamin)||25 mcg||417%|
|Zinc (as zinc-bisglycinate chelate||15 mg||100%|
|Succinic Acid||50 mg||†|
|Desiccated Stomach Substance||100 mg||†|
|†Daily Value (DV) not established|
Dicalcium phosphate, microcrystalline cellulose, croscarmelose sodium, vegetable stearate, silicon dioxide.
Niferex™ is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.
DOSAGE AND ADMINISTRATION
Before, during and/or after pregnancy, one tablet daily or as directed by a physician.
Bottles of 30 tablets (75854-321-30). The listed product number is not a National Drug Code. Instead, Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.
Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature.]
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Manufactured for: Avion Pharmaceuticals, LLC, Alpharetta, GA 30022. Revised: Mar 2017
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
No information provided.
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
Women's Conditions Resources
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.